We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
126
Tesla
TSLA
$1.3T
$32.5M 0.21%
+227,115
New +$26.8M
LRCX icon
127
Lam Research
LRCX
$390B
$32.4M 0.21%
977,150
-63,610
-6% -$2.19M
NSC icon
128
Norfolk Southern
NSC
$75.1B
$32.3M 0.21%
151,121
-20,968
-12% -$4.21M
NEM icon
129
Newmont
NEM
$119B
$32M 0.21%
504,925
+446,192
+760% +$29.1M
TRIL
130
DELISTED
Trillium Therapeutics Inc.
TRIL
$31.4M 0.2%
2,209,343
-324,446
-13% -$3.23M
BKNG icon
131
Booking.com
BKNG
$161B
$31.3M 0.2%
457,325
+94,650
+26% +$6.65M
CSL icon
132
Carlisle Companies
CSL
$15.4B
$31M 0.2%
253,489
-14,390
-5% -$1.77M
GDRX icon
133
GoodRx Holdings
GDRX
$1.26B
$30.7M 0.2%
+552,973
New +$29.3M
AVY icon
134
Avery Dennison
AVY
$13.4B
$30M 0.19%
234,298
-166,867
-42% -$19.7M
TJX icon
135
TJX Companies
TJX
$178B
$29.9M 0.19%
538,060
+375,485
+231% +$20.2M
TSM icon
136
TSMC
TSM
$2.18T
$29.9M 0.19%
368,537
-318,056
-46% -$24.2M
WMT icon
137
Walmart Inc
WMT
$890B
$29.9M 0.19%
640,515
-975,684
-60% -$43.4M
LMT icon
138
Lockheed Martin
LMT
$136B
$29.7M 0.19%
77,599
-153,508
-66% -$58.6M
OPTU
139
Optimum Communications Inc
OPTU
$301M
$29.4M 0.19%
1,131,641
-725,329
-39% -$18.8M
BDX icon
140
Becton Dickinson
BDX
$48.2B
$29.3M 0.19%
+129,075
New +$31.7M
CME icon
141
CME Group
CME
$94.8B
$29.2M 0.19%
174,355
+89,974
+107% +$15.2M
TDG icon
142
TransDigm Group
TDG
$67.7B
$28.4M 0.18%
+59,840
New +$28.1M
MKC icon
143
McCormick & Company Non-Voting
MKC
$14.2B
$28.4M 0.18%
292,720
+135,606
+86% +$13.3M
MCO icon
144
Moody's
MCO
$82.7B
$28.1M 0.18%
96,894
+61,334
+172% +$17.5M
V icon
145
Visa
V
$677B
$27.9M 0.18%
139,606
-349,464
-71% -$69.8M
OC icon
146
Owens Corning
OC
$12.4B
$27.7M 0.18%
402,376
+392,240
+3,870% +$25.2M
DG icon
147
Dollar General
DG
$27.9B
$27.4M 0.18%
130,859
-203,977
-61% -$40.1M
ATVI
148
DELISTED
Activision Blizzard
ATVI
$27.2M 0.17%
336,271
-451,020
-57% -$36.6M
VRTX icon
149
Vertex Pharmaceuticals
VRTX
$126B
$27M 0.17%
99,366
-140,898
-59% -$38.9M
FTV icon
150
Fortive
FTV
$18.6B
$26.7M 0.17%
+555,738
New +$25.3M

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.